Welcome to the Epidemic Preparedness Innovations (EPI) web space. This platform has been set up by the Coalition for Epidemic Preparedness Innovations (CEPI). It aims to bring together knowledge, tools and methods to support vaccine researchers, developers, funders and anybody working on or interested in the field of epidemic preparedness innovations.
Statement from CEO of CEPI, Dr. Richard Hatchett, on the announcement today, 9 November 2020, from Pfizer / BioNTech with interim data from their Phase III clinical trial indicating ...
In this Summary Document, we evaluate, from a clinical perspective, the burden of disease (BOD) endpoint recently proposed by Mehrotra et.al. for its suitability as a primary endpoint for assessing COVID-19 vaccine efficacy. Read more
FDA is issuing this guidance to provide sponsors of requests for Emergency Use Authorization (EUA) for COVID-19 vaccines… Read more
CEPI has compiled COVID-19-specific national requirements and guidelines to conduct clinical trials in multiple countries across the globe, together with links to the respective regulatory authorities and ethics committees ... Read more
